Open AccessThis article is
- freely available
Cytotoxicity of Two Triterpenoids from Nigella glandulifera
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100094, P.R. China
Children’s Hospital Informatics Program at Harvard–MIT Division of Health Sciences and Technology, Children’s Hospital Boston, Harvard Medical School, Boston, MA 02115, U.S.A.
College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, P.R. China
* Authors to whom correspondence should be addressed.
Received: 25 July 2006; in revised form: 28 August 2006 / Accepted: 30 August 2006 / Published: 13 September 2006
Abstract: During an investigation of antitumor substances from Nigella glandulifera Freyn et Sint. (Ranunculaceae) the cytotoxicity of two oleanane triterpene saponins isolated from the seeds of this species, kalopanaxsaponins A and I, was evaluated against HepG2, drug resistant HepG2 (R-HepG2) (two hepatocyte cell lines) and primary cultured normal mouse hepatocytes. Evident cytotoxic activities were observed. Morphological observations and cell cycle analysis suggest that these compounds inhibit the proliferation of hepatoma by inducing apoptosis and consequently kalopanaxsaponins A and I may be potential therapeutic agents for the treatment of parental and drug resistant hepatoma.
Keywords: Nigella glandulifera; oleanane type saponins; cytotoxicity; HepG2; apoptosis
Citations to this Article
Cite This Article
MDPI and ACS Style
Tian, Z.; Liu, Y.-M.; Chen, S.-B.; Yang, J.-S.; Xiao, P.-G.; Wang, L.; Wu, E. Cytotoxicity of Two Triterpenoids from Nigella glandulifera. Molecules 2006, 11, 693-699.
Tian Z, Liu Y-M, Chen S-B, Yang J-S, Xiao P-G, Wang L, Wu E. Cytotoxicity of Two Triterpenoids from Nigella glandulifera. Molecules. 2006; 11(9):693-699.
Tian, Ze; Liu, Yu-Ming; Chen, Si-Bao; Yang, Jun-Shan; Xiao, Pei-Gen; Wang, Liao; Wu, Erxi. 2006. "Cytotoxicity of Two Triterpenoids from Nigella glandulifera." Molecules 11, no. 9: 693-699.